Document And Entity Information [Abstract] Document Information [Table] Class of Stock [Axis] Class of Stock [Axis] Document Type Amendment Flag Document Period End Date Document Fiscal Year Focus Document Fiscal Period Focus Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Filer Category Entity Public Float Trading Symbol Entity Common Stock, Shares Outstanding Research and License Agreement [Text Block] Research and License Agreement [Text Block] The entire disclosure on research and license agreement entered by the entity. Stockholders' Equity Note [Abstract] Stockholders Equity Note Disclosure [Text Block] Stockholders' Equity Note Disclosure [Text Block] Subsequent Events [Abstract] Subsequent Events [Text Block] Subsequent Events [Text Block] Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Schedule Of Warrants Issued To Investors Service Providers [Table Text Block] Schedule Of Share-Based Compensation, Stock Options, Activity [Table Text Block] Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Accounting Policies [Abstract] General And Going Concern [Table] Related Party [Axis] Related Party [Axis] Related Party [Domain] Related Party [Domain] Class Of Stock [Domain] Class of Stock [Domain] General And Going Concern [Line Items] Research and License Agreement [Abstract] Research And License Agreement [Table] Income Statement Location [Axis] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Research And License Agreement [Line Items] Percentage Of Royalty PaymentIf Licensed Product Covered By Valid Claim Or Orphan Drug Status Percentage Of Royalty Payment If Licensed Product Covered By Valid Claim Or Orphan Drug Status This element represents the percentage of all net sales royalty that the company will pay if the making, producing, manufacturing, using, marketing, selling, importing or exporting of such Licensed Product is covered by a Valid Claim or is covered by Orphan Drug Status Percentage Of Royalty Payment If Licensed Product Not Covered By Valid Claim Or Orphan Drug Status This element represents the percentage of all net sales royalty that the company will pay if the making, producing, manufacturing, using, marketing, selling, importing or exporting of such Licensed Product is not covered by a Valid Claim or is not covered by Orphan Drug Status. Validity Of Royalty Payment Not Covered By Valid Claim Or Orphan Drug Status This element represents the validity of the royalties' payments by the company not covered by a Valid Claim or Orphan Drug Status. Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Award Type [Axis] Award Type [Axis] Award Type [Domain] Award Type [Domain] Employee Stock Option [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Beginning Balance Amount of options, Outstanding at beginning of period Amount of options, Outstanding at end of period Options outstanding at end of period Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Gross Amount of options, Granted Number of warrants issued Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Gross Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Amount of options, Exercised Exercised Exercise of options (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Amount of options, Cancelled Forfeited Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Vested and Expected To Vest, Outstanding, Number Amount of options, Vested and expected-to-vest at end of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Beginning Balance Weighted average exercise price, Outstanding at beginning of period (in dollars per share) Weighted average exercise price, Outstanding at end of period (in dollars per share) Exercise price (in dollars per share) Exercise price (in dollars per share) Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Grants In Period, Weighted Average Exercise Price Weighted average exercise price, Granted (in dollars per share) Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Exercises In Period, Weighted Average Exercise Price Weighted average exercise price, Exercised (in dollars per share) Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Forfeitures In Period, Weighted Average Exercise Price Weighted Average exercise Price, Cancelled (in dollars per share) Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Vested and Expected To Vest, Outstanding, Weighted Average Exercise Price Weighted average exercise price, Vested and expected-to-vest at end of period (in dollars per share) Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Intrinsic Value Aggregate intrinsic value, Outstanding at end of period (in dollars) Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Vested and Expected To Vest, Outstanding, Aggregate Intrinsic Value Aggregate intrinsic value, Vested and expected-to-vest at end of period (in dollars) Statement Of Financial Position [Abstract] Statement [Table] Statement [Table] Statement [Line Items] Statement [Line Items] Assets [Abstract] ASSETS Assets, Current [Abstract] Current Assets: Cash and Cash Equivalents, at Carrying Value, Total Cash and cash equivalents Cash and cash equivalents at the beginning of the period Cash and cash equivalents at end of the period Short-term Investments, Total Short-term deposit (Note 8) Nontrade Receivables, Current, Total Account receivable (Note 4) Non-trade Receivables, Current, Total Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Assets, Current, Total Total current assets Prepaid Expense and Other Assets, Total Prepaid expenses and other long-term assets (Note 5) Assets, Total Total assets Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities, Current [Abstract] Current Liabilities: Accounts Payable, Current Accounts payables Accrued Liabilities, Current Accrued expenses Deferred Grant Income Deferred grant income (Note 9) The carrying value for deferred grant income was received. Accounts Payable, Other, Current Other accounts payable Liabilities, Total Total liabilities Stockholders Equity Attributable To Parent [Abstract] Stockholders' Equity: Liabilities and Equity Total liabilities and stockholders' equity Common Stock, Value, Issued Stock capital: (Note 10) Common Stock of $0.00005 par value - Authorized: 100,000,000 shares at December 31, 2017 and December 31, 2016 respectively; Issued and outstanding: 18,976,169 and 18,687,987 shares at December 31, 2017 and December 31, 2016 respectively. Additional Paid In Capital, Common Stock Additional paid-in-capital Retained Earnings (Accumulated Deficit) Accumulated deficit Stockholders Equity Attributable To Parent Total stockholders' equity Balance Balance Liabilities, Noncurrent [Abstract] Long-Term Liabilities: Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Research and Development Expense [Member] Research and development [Member] General and Administrative Expense [Member] General and administrative [Member] Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] Share-based Compensation, Total Total stock-based compensation expense Subsidiary, Sale Of Stock [Axis] Subsidiary, Sale of Stock [Axis] Sale Of Stock, Name Of Transaction [Domain] Sale of Stock, Name of Transaction [Domain] Private Placement [Member] Investors Private Placement [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Equity Components [Axis] Statement, Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Warrant Issued One [Member] Warrant Issued One Member. Unregistered Shares of Common Stock [Member] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Option Indexed To Issuer'S Equity, Type [Axis] Option Indexed to Issuer's Equity, Type [Axis] Option Indexed To Issuer'S Equity, Type [Domain] Option Indexed to Issuer's Equity, Type [Domain] Global Share Option Plan 2014 and U S Stock Option and Incentive Plan 2014 [Member] Title of Individual [Axis] Deferred Bonus and Profit Sharing Plan by Title of Individual [Axis] Title Of Individual With Relationship To Entity [Domain] Title of Individual with Relationship to Entity [Domain] Director [Member] Chief Operating Officer [Member] Chief Executive Officer [Member] Mr Schor [Member] Mr. Schor [Member] Chief Financial Officer [Member] Restricted Stock [Member] Variable Interest Entities [Axis] Variable Interest Entities [Axis] Variable Interest Entity, Classification [Domain] Variable Interest Entity, Classification [Domain] Products and Services [Axis] Products and Services [Axis] Products and Services [Domain] Products and Services [Domain] Legal Advisor [Member] Consultants [Member] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event [Member] Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] Investment Type [Axis] Investment Type [Axis] Investments [Domain] Investments [Domain] Investment Agreement [Member] Investment Agreement Member. Stock Issued During Period, Shares, New Issues Issuance of shares for public offering (in shares) Stock Based Compensation Recorded In General and Administrative Expenses Stock Based Compensation Recorded In General and Administrative Expenses The amount refers to stock based compensation that was recorded in general and administrative expenses. Proceeds From Issuance Of Common Stock Proceeds from issuance of Common stock, net Warrants Issued To Purchase Of Common Stock Warrants Issued To Purchase Of Common Stock Number of warrants issued to purchase of common stock. Investment Warrants, Exercise Price Exercise Price (in dollars per share) Investment Warrants, Exercise Price Stock Issued During Period, Shares, Issued For Services Stock Issued During Period, Shares, Issued for Services Share-Based Compensation Arrangement By Share-Based Payment Award, Award Vesting Period Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Stock Issued During Period, Value, New Issues Amount raised in Public offering Issuance of shares for public offering Shares Issued, Price Per Share Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights Balance Sheet Parenthetical [Abstract] Balance Sheet Parenthetical Statement, Scenario [Axis] Scenario, Unspecified [Domain] Common Stock, Par Or Stated Value Per Share Common stock, par value (in dollars per share) Common Stock, Shares Authorized Common stock, shares Authorized Common Stock, Shares, Issued Common stock, shares Issued Common Stock, Shares, Outstanding Common stock, shares outstanding Income Statement [Abstract] Operating Expenses [Abstract] Operating expenses: Research and Development Expense, Total Research and Development Expense Research and development, net (Note 11) General and Administrative Expense General and administrative Operating Income (Loss) Operating loss Financial Expenses Income Net Financial expenses (income), net Amount of financial expenses (income), net during the period. Income Tax Expense (Benefit) Taxes on income (Note 12) Net Income (Loss) Attributable to Parent, Total Net loss Net loss Net loss Income (Loss) From Continuing Operations, Per Basic and Diluted Share Basic and diluted net loss per share from continuing operations (in dollars per share) Weighted Average Number Of Shares Outstanding, Basic and Diluted Weighted average number of shares outstanding used in computing basic and diluted net loss per share (in shares) Statement Of Stockholders Equity [Abstract] Common Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Accumulated Deficit [Member] Shares, Outstanding Balance (in shares) Balance (in shares) Stock Granted During Period, Value, Share-Based Compensation, Net Of Forfeitures Stock-based compensation related to warrants and stock granted to service providers Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Net Of Forfeitures Stock-based compensation related to warrants and stock granted to service providers (in shares) Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures Stock-based compensation related to stock and options granted to directors and employees Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures Stock-based compensation related to stock and options granted to directors and employees (in shares) Statement Of Cash Flows [Abstract] Net Cash Provided by (Used in) Operating Activities [Abstract] Cash flows from operating activities: Adjustments To Reconcile Net Income (Loss) To Cash Provided By (Used In) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Depreciation Depreciation Issuance of Stock and Warrants for Services or Claims Shares and options granted to service providers Stock Or Unit Option Plan Expense Deferred Stock-based compensation related to options granted to employees and directors Increase Decrease In Accounts Receivable and Prepaid Expenses Decrease (increase) in accounts receivable and prepaid expenses The increase (decrease) during the reporting period in accounts receivable and prepaid expenses. Increase (Decrease) In Accounts Payable, Trade Increase (decrease) in trade payables Increase Decrease In Deferred Grant Income Deferred grant income The increase (decrease) Deferred Grant Income during the reporting period. Increase (Decrease) In Other Accounts Payable and Accrued Liabilities Increase (decrease) in other accounts payable and accrued expenses Net Cash Provided by (Used in) Operating Activities Total net cash used in operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] Cash flows from investing activities: Payments To Acquire Property, Plant, and Equipment Purchase of property and equipment Payments for (Proceeds from) Investments Changes in short-term deposit Net Cash Provided by (Used in) Financing Activities [Abstract] Cash flows from financing activities: Proceeds from Warrant Exercises Proceeds from exercise of warrants and options Cash and Cash Equivalents, Period Increase (Decrease) Increase in cash and cash equivalents Noncash Investing and Financing Items [Abstract] Non-cash financing activities: General and Going Concern Disclosure [Abstract] Business Description and Basis of Presentation [Text Block] Business Description and Basis of Presentation [Text Block] Basis of Presentation and Significant Accounting Policies [Text Block] Basis of Presentation and Significant Accounting Policies [Text Block] Basis of Accounting, Policy [Policy Text Block] Use of Estimates, Policy [Policy Text Block] Foreign Currency Transactions and Translations Policy [Policy Text Block] Consolidation, Policy [Policy Text Block] Cash and Cash Equivalents, Policy [Policy Text Block] Property, Plant and Equipment, Policy [Policy Text Block] Severance Pay Policy [Policy Text Block] Disclosure of accounting policy for severance Pay. Fair Value of Financial Instruments, Policy [Policy Text Block] Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Earnings Per Share, Policy [Policy Text Block] Research and Development Expense, Policy [Policy Text Block] Schedule Of Depreciation Rates For Property Plant And Equipment [Table Text Block] Tabular disclosure of depreciation rates for property, plant and equipment over the estimated useful lives. Property, Plant and Equipment [Table] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Domain] Office Equipment [Member] Office furniture and equipment [Member] Computer Equipment [Member] Computer software and electronic equipment [Member] Laboratory Equipment [Member] Laboratory equipment [Member] Land Improvements [Member] Leasehold improvements [Member] Property, Plant and Equipment [Line Items] Property Plant and Equipment Depreciation Rates Property Plant and Equipment Depreciation Rates The depreciation rate recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Accounting Policies [Table] Accounting Policies [Line Items] Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay Receivables [Abstract] Loans, Notes, Trade and Other Receivables Disclosure [Text Block] Schedule of Other Current Assets [Table Text Block] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Accounts, Notes, Loans and Financing Receivable [Line Items] Grants Receivable, Current Grants receivable from IIA Value Added Tax Receivable, Current Government institutions and other Property, Plant and Equipment [Abstract] Property, Plant and Equipment Disclosure [Text Block] Property, Plant and Equipment [Table Text Block] Property, Plant and Equipment, Net [Abstract] Property, Plant and Equipment: Property, Plant and Equipment, Gross Cost Related Party Transactions [Abstract] Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Accumulated depreciation Property, Plant and Equipment, Net, Total Depreciated cost Property and Equipment, Net (Note 6) Related Party Transactions Disclosure [Text Block] Leasehold Improvements [Member] Leasehold improvements [Member] Income Tax Disclosure [Abstract] Income Tax Disclosure [Text Block] Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Income Tax Disclosure [Table] Operating Loss Carryforwards Operating loss carryforward Deferred Tax Assets, Gross Net deferred tax asset before valuation allowance Deferred Tax Assets, Valuation Allowance Valuation allowance Deferred Tax Assets, Net Net deferred tax asset Income (Loss) from Continuing Operations before Income Taxes, Domestic United States Income (Loss) from Continuing Operations before Income Taxes, Foreign Israel Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest Loss from continuing operations, before taxes on income Income Tax Authority [Axis] Preferred Area [Axis] Income Tax Authority [Domain] Israel Country [Member] Preferred Area [Domain] B C T Income Tax rate BCT Income Tax rate The element represents the statutory Tax rate applicable to the subsidiary (BCT) located in Israel. Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Text Block] Operating Loss Carryforwards, Valuation Allowance Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Commitments And Contingencies [Table] Facilities [Member] Vehicles [Member] Commitments And Contingencies [Line Items] Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] Period ending December 31,2017 Operating Leases, Future Minimum Payments Due, Next Twelve Months 2018 Operating Leases, Future Minimum Payments, Due in Two Years 2019 Operating Leases, Future Minimum Payments, Due in Three Years 2020 Operating Leases, Future Minimum Payments Due Operating Leases Future Minimum Payments Due Research and Development [Abstract] Type Of Agreement [Axis] Type Of Agreement [Domain] Lease Agreement [Member] Research and Development Disclosure [Table Text Block] Tabular disclosure of research and development. Research and Development Arrangement [Table] Project [Axis] Legal Entity [Axis] Project [Domain] Research and Development Cost Research and development The cost associated with research and development charges incurred during the period. Research and Development Arrangement, Contract to Perform for Others, Compensation Earned Less : Participation Litigation Case [Axis] Litigation Case [Domain] Lease Agreement Entry Date The date on which the lease agreement is entered into the amended lease agreement. Lease Agreement Term The term of lease as per the agreement. Operating Leases, Rent Expense, Minimum Rentals Percentage Of Royalty Payments Agreed For Grants The percentage of royalty payments obligated to be paid as per the agreement for grants received for participation in research Grants Underlying Basis The underlying basis on which the grants are linked. Amounts Of Grants Received The cash inflow from grants received during the period. Monthly Rental Payments Agreed The amount agreed to be paid per month for rental and operation of two clean rooms Minimum [Member] Maximum [Member] Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block] Schedule Of Employee Service Share-Based Compensation, Allocation Of Recognized Period Costs [Table Text Block] Stock Based Compensation Expense [Table Text Block] Operating Leases, Rent Expense Area of Land Lessee Leasing Arrangements, Operating Leases, Term of Contract Maxim Group LLC [Member] Lease Agreement Termination Description These lines are represents the description of lease agreement termination. Tax Credit Carryforward, Amount Income Tax Disclosure [Line Items] Income Tax, Policy [Policy Text Block] Stock Issued During Period, Value, Stock Options Exercised Exercise of options Stock Issued During Period, Value, Exercise Of Warrants Exercise of warrants Value of stock issued during the period as a result of exercise of warrants Stock Issued During Period, Shares, Exercise Of Warrants Exercise of warrants (in shares) Number of shares issued during the period as a result of exercise of warrants Agreement [Domain] Cash and Cash Equivalents [Abstract] Short Term Investments [Text Block] he entire disclosure of the components short-term investments. Short-term investments may include current marketable securities. Entity [Domain] Percentage Of Interest Bearing Bank Deposits Percentage of Interest Bearing Bank Deposits Percentage of interest-bearing bank deposits. Maturity of Time Deposits Cash and Cash Equivalents [Line Items] New Accounting Pronouncements, Policy [Policy Text Block] Proceeds from Issuance of Common Stock, Net The net cash inflow from the additional capital contribution to the entity. Assets, Noncurrent [Abstract] Long-Term Assets: Other Assets, Noncurrent Total Long-Term Assets Net Cash Provided by (Used in) Financing Activities Total net cash provided by financing activities Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table] Exercise Price Range [Axis] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain] Exercise Price 0.75 [Member] Exercise Price 1.005 [Member] Exercise Price 2.25 [Member] Exercise Price 2.45 [Member] Exercise Price 2.70 [Member] Exercise Price 3.17 [Member] Exercise Price 3.90 [Member] Exercise Price 4.80 [Member] Exercise Price 5.85 [Member] Exercise Price 7.05 [Member] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted average remaining contractual Life Years Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Warrants exercisable Options exercisable Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Axis] Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk-free interest Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Expected life of up to (years) Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Domain] Plan Name [Axis] Tax Credit Carryforward Expiration Period Expiration period of the tax credit carryforward. Research, Development, and Computer Software Disclosure [Text Block] Proceeds from Issuance or Sale of Equity Proceeds from equity offering through issuances of equity warrants and common stock through the exercise of previously issued equity warrants Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Liabilities, Current, Total Total current liabilities Investment In Lease Deposit Investment in lease deposit Amount of investment made in the form of lease deposit during the year. Deferred Grant Income [Abstract] Deferred Grant Income [Text Block] The entire disclosure for deferred grant income. Proceeds from Grantors Grants Receivable California Institute Of Regenerative Medicine [Member] Schedule Stock Awards Activity Related To Service Providers [Table Text Block] Tabular disclosure includes the number and weighted-average issue prices for warrants issued to services providers that were outstanding at the beginning and end of the year, and issued during the year. Class of Warrant or Right, Outstanding Outstanding Class of Warrant or Right, Exercise Price of Warrants or Rights Warrant Exercisable Term Exercisable through Date the warrants or rights are exercisable, in CCYY-MM-DD format. Nov 08 [Member] Nov-08 [Member] April-Oct 2009 [Member] April 2007-Jan 2011 [Member] Jan 15 [Member] Jan-15 [Member] Research and Development Arrangement [Line Items] Exercise Price 4.18 [Member] Exercise Price 4.3 [Member] Exercise Price 4.81 [Member] Warrant Amendment Agreement,Description The description of the warrant amendment agreement. Common Stock, Capital Shares Reserved for Future Issuance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Executive Vice President, Chief Business Officer and Director [Member] Vice Presidents [Member] Patient Advocacy and Government Affairs [Member] Dr Arbel [Member] Dr Shorr [Member] Mr Taub [Member] Agreement [Axis] Plan Name [Domain] Second Amended and Restated Director Compensation Plan [Member] Stock Issued During Period, Shares, Restricted Stock Award, Gross Document Information [Line Items] Net Cash Provided by (Used in) Investing Activities Total net cash provided by investing activities Prepaid Expenses Disclosures [Abstract] Mr. Yablonka [Member] Prepaid Expenses Disclosures [Text Block] The entire disclosure for Prepaid Expenses. City of Hope [Member] Payments to Suppliers Warrants Excercised The number of warrants exercised during the year. Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Warrants Expired The number of warrants expired during the year. Scenario, Plan [Member] Prepaid Supplies Prepaid Expense, Current Prepaid Expense, Noncurrent Israel Innovation Authorities [Member]